Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received U.S. Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) for Norepinephrine ...

Biocon’s subsidiary Biocon Pharma has received the Food and Drug Administration’s permission for norepinephrine bitartrate injection (4 mg/4 ml, 1 mg/ml) in a single-dose vial, the company ...

India's Biocon has expanded its pipeline of biosimilars with a $3.3 billion deal to acquire a portfolio of drugs from Viatris, the parent of its longstanding partner Mylan, which will boost its ...

Stock market live updates today: Biocon Pharma, wholly-owned arm of Biocon, receives USFDA approval for injection; stock inches up on NSE Biocon Pharma Ltd, a wholly-owned subsidiary of Biocon ...

Shares of the pharmaceutical company, Biocon, were ruling higher on the bourses on Monday, March 24, 2025. The company's share price advanced 2.23 per cent to a day's high of ₹351.80 per share on the ...

Biocon on Monday, March 24, said its subsidiary Biocon Pharma, has received approval from the US and Drug Administration (FDA) for the norepinephrine bitartrate injection. The approval of ...

Biocon added 1.34% to Rs 348.55 after the company's wholly owned subsidiary Biocon Pharma announced the receipt of U.S Food and Drug Administration (US FDA) approval for its ANDA Norepinephrine ...

The smart factory, which is part of ABBs manufacturing 19-acre Nelamangala campus, will house the production line for the entire range of ABBs protection and connection business, which helps to ...

The global business of the Bank increased to 22,72,968 crore, up by 11.31% y-o-y, out of which domestic business grew by 11.01% y-o-y to 21,23,133 crore as at March 2024. Domestic CASA deposits ...

At close: 3:30:01 PM GMT+5:30 Loading Chart for BIOCON.NS ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.